Treatment-Completion Rates With Olanzapine Long-Acting Injection Versus Risperidone Long-Acting Injection in a 12-Month, Open-Label Treatment of Schizophrenia: Indirect, Exploratory Comparisons
International Journal of General Medicine - New Zealand
doi 10.2147/ijgm.s29052
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2012
Authors
Publisher
Informa UK Limited